Literature DB >> 15918190

Expression and purification of the complete PreS region of hepatitis B Virus.

Qiang Deng1, Yu-Ying Kong, You-Hua Xie, Yuan Wang.   

Abstract

AIM: To express the complete PreS region of HBV in E.coli with good solubility and stability, and to establish an effective method for purification of the recombinant PreS protein.
METHODS: The complete PreS region (PreS1 and PreS2) was fused into a series of tags including glutathione S-transferase (GST), dihydrofolate reductase (DHFR), maltose binding protein (MBP), 6x histidine, chitin binding domain (CBD), and thioredoxin, respectively. Expression of recombinant PreS fusion proteins was examined by SDS-PAGE analysis and confirmed by Western blot. Two fusion proteins, thio-PreS, and PreS-CBD, with desirable solubility and stability, were subjected to affinity purification and further characterization.
RESULTS: Recombinant PreS fusion proteins could be synthesized with good yields in E.coli. However, most of these proteins except for thio-PreS and PreS-CBD were vulnerable to degradation or insoluble as revealed by SDS-PAGE and Western blot. Thio-PreS could be purified by affinity chromatography with nickel-chelating sepharose as the matrix. However, some impurities were also co-purified. A simple freeze-thaw treatment yielded most of the thio-PreS proteins in solution while the impurities were in the precipitate. Purified thio-PreS protein was capable of inhibiting the binding of HBV virion to a specific monoclonal antibody against an epitope within the PreS1 domain.
CONCLUSION: Increased solubility and stability of the complete PreS region synthesized in E.coli can be achieved by fusion with the thioredoxin or the CBD tag. A simple yet highly effective method has been established for the purification of the thio-PreS protein. Purified thio-PreS protein likely assumes a native conformation, which makes it an ideal candidate for studying the structure of the PreS region as well as for screening antivirals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15918190      PMCID: PMC4305840          DOI: 10.3748/wjg.v11.i20.3060

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

Review 1.  Overview of tag protein fusions: from molecular and biochemical fundamentals to commercial systems.

Authors:  K Terpe
Journal:  Appl Microbiol Biotechnol       Date:  2002-11-07       Impact factor: 4.813

2.  Importance of subtype in the immune response to the pre-S(2) region of the hepatitis B surface antigen. II. Synthetic Pre-S(2) immunogen.

Authors:  D R Milich; J E Jones; A McLachlan; G Bitter; A Moriarty; J L Hughes
Journal:  J Immunol       Date:  1990-05-01       Impact factor: 5.422

Review 3.  The pre-S region of hepadnavirus envelope proteins.

Authors:  A R Neurath; S B Kent
Journal:  Adv Virus Res       Date:  1988       Impact factor: 9.937

4.  A short linear sequence in the pre-S domain of the large hepatitis B virus envelope protein required for virion formation.

Authors:  V Bruss
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

5.  Coordinate regulation of replication and virus assembly by the large envelope protein of an avian hepadnavirus.

Authors:  R J Lenhoff; J Summers
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

6.  Expression and characterization of chimeric hepatitis B surface antigen particles carrying preS epitopes.

Authors:  J Hui; G Li; Y Kong; Y Wang
Journal:  J Biotechnol       Date:  1999-06-11       Impact factor: 3.307

7.  Cloning, expression, isolation and characterization of the pre-S domains of hepatitis B surface antigen, devoid of the S protein.

Authors:  S Delos; M T Villar; P Hu; D L Peterson
Journal:  Biochem J       Date:  1991-06-01       Impact factor: 3.857

8.  Affinity Purification of Hepatitis B Virus Surface Antigen Containing PreS1 Region.

Authors:  Hai-Lin Yang; Yi Jin; Hui-Ting Cao; Xie Xu; Guang-Di Li; Yuan Wang; Zu-Chuan Zhang
Journal:  Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai)       Date:  1996

9.  Cloning, expression, and purification of histidine-tagged preS domains of hepatitis B virus.

Authors:  E Núñez; X Wei; C Delgado; I Rodríguez-Crespo; B Yélamos; J Gómez-Gutiérrez; D L Peterson; F Gavilanes
Journal:  Protein Expr Purif       Date:  2001-02       Impact factor: 1.650

10.  A dramatic shift in the transmembrane topology of a viral envelope glycoprotein accompanies hepatitis B viral morphogenesis.

Authors:  P Ostapchuk; P Hearing; D Ganem
Journal:  EMBO J       Date:  1994-03-01       Impact factor: 11.598

View more
  4 in total

1.  Screening for PreS specific binding ligands with a phage displayed peptides library.

Authors:  Qiang Deng; Ming Zhuang; Yu-Ying Kong; You-Hua Xie; Yuan Wang
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

2.  Identification and characterization of peptides that interact with hepatitis B virus via the putative receptor binding site.

Authors:  Qiang Deng; Jian-wei Zhai; Marie-Louise Michel; Jun Zhang; Jun Qin; Yu-ying Kong; Xin-xin Zhang; Agata Budkowska; Pierre Tiollais; Yuan Wang; You-hua Xie
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

3.  Hepatitis B virus (HBV) surface antigen interacts with and promotes cyclophilin a secretion: possible link to pathogenesis of HBV infection.

Authors:  Xiaochen Tian; Chao Zhao; Hongguang Zhu; Weimin She; Jiming Zhang; Jing Liu; Lanjuan Li; Shusen Zheng; Yu-Mei Wen; Youhua Xie
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

Review 4.  Phage display creates innovative applications to combat hepatitis B virus.

Authors:  Wen Siang Tan; Kok Lian Ho
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.